#co-pay

Pharma sets the prices for HIV and hep C drugs very high. What happens to those prices along the supply chain?

Stop me if you’ve heard this one before.

The patient advocacy coalition I Am Essential sent a letter to the HHS spelling out why the plan is dangerous.

Health coalition warns the federal government: People with chronic or serious conditions face growing costs at the pharmacy.

Among other issues: Out-of-pocket costs are increasingly passed on to consumers.

60 groups sign a letter to state insurance commissioners and attorneys general asking them to reverse the policy.

My fear of the dentist was setting me up for a future of teeth loss.

In summary: Bandage it or blow it up?

ViiV Healthcare, which makes several antiretroviral (ARV) drugs, is expanding programs to help HIV-positive people access the company’s...

Gilead Sciences and Bristol-Myers Squibb have announced that the co-payment assistance program for Atripla (containing efavirenz...

Drug shortages spike co-pays for some people with HIV.

ViiV Healthcare—an HIV-focused company established by GlaxoSmithKline (GSK) and Pfizer—announced it will continue a drug co-paymen...

The prescription co-payment programs run by Bristol-Myers Squibb (BMS) will now begin with the first dollar a person pays a pharmacy or...